Cadila share price dipped 8 per cent to Rs.374 on the Bombay Stock Exchange (BSE) in intra-day after the firm registered 29 per cent year-on-year (YoY) dip in its consolidated net profit at Rs.338 cr for the quarter ended September 30, 2016 (Q2FY17). Market analysts on an average had expected profit of Rs.380 cr. The pharmaceutical company had a profit of Rs.416 cr in the same quarter year ago.
The total income from operations remain flat at Rs.2,404 cr in Q2FY17 as compared to Rs.2,395 cr in the corresponding quarter of previous fiscal. At 14:31 PM, Cadila share price was down 4.36 per cent at Rs.390.05 on the NSE. A combined 2.39 million shares changed hands as compared to an average sub 500,000 shares which were traded daily in past 2 weeks on the BSE and NSE.
CADILA share price history:
Cadila share price opened at Rs. 409.05 from a previous closing of Rs. 407.85 on the National Stock Exchange (NSE) today. CADILA Healthcare is analyzed by Dynamic Levels Researchers and analysts as the top 500 performing stocks for the current quarter among the 1700 stocks which are listed on the National Stock Exchange (NSE). Cadila is fundamentally strong and is safe for investment, as per Dynamic analysts and market experts.
The company a market cap of Rs. 41753.34 (Cr) while its book value stands at 52.28. The 52-week high of the stock stands at Rs. 445.00 on 26-Oct-15 while the 52-week low reads at Rs 295.00 on 21-Jan-16. The life time high & low of the stock stands at Rs. 453.30 on 23-Oct-15 and Rs. 5.53 on 25-Jul-01, respectively.
In order to gain information about the support and resistance levels of the scrip and also its fundamentals and financials, please a pay a visit to CADILA share price history.
No comments:
Post a Comment